Skip to main content
Erschienen in: BMC Urology 1/2020

Open Access 01.12.2020 | Research article

The utility of intravenous ketamine for the management of intraoperative penile erection: a retrospective single-center analysis of endourological surgeries over a 4-year

verfasst von: Aşkın Eroğlu, Bahattin Tuncalı, Rahmi Gökhan Ekin

Erschienen in: BMC Urology | Ausgabe 1/2020

Abstract

Background

To assess the prevalence of intraoperative penile erection in our endourology practice and the utility of intravenous ketamine in the management of the condition.

Methods

Of 402 endoscopic urological procedures performed in our clinic over a 4-year (2015–2019) period, a total of 9 cases with intraoperative penile erection impeding instrumentation during endourological surgery were included. Data on patient age, weight, height, American Society of Anesthesiologists (ASA) physical status classification system scores, type and duration of surgery, type and level of anesthesia, onset of erection, treatment characteristics and treatment outcome were recorded for each patient.

Results

The mean (SD) age was 68.3 years (range, 66.0–77.0 years). ASA physical status category I and II were noted in 55.6 and 44.4% of patients, respectively. All cases received spinal anesthesia (n = 9) at T8–10 dermatome levels, for TURP in 7 (77.8%) cases and for TURBT in 2 (22.2%) cases. The onset of penile erection was post-urethroscope in 7 (77.8%) cases. The average total ketamine dose was 34.3 mg (range, 18.0–75.0 mg). The average duration of the operation was 91.7 min (range, 40.0–140.0 min). Ketamine treatment resulted in resolved erection with delayed procedure in 7 (77.8%) cases, while conversion to general anesthesia was required in 2 (22.5%) cases.

Conclusions

In conclusion, the prevalence of intraoperative penile erection during spinal anesthesia for endourological surgery was 2.2% in our experience. These findings demonstrated that intravenous injection of ketamine is an effective and safe method for immediate resolution of intraoperative penile erection with a high success rate.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ASA
American society of anesthesiologists
TURBT
Transurethral resection of bladder tumor
TURP
Transurethral resection of prostate

Background

Penile tumescence resulting in partial or total erection under anesthesia at the time of endoscopic urological surgery is a relatively infrequent but challenging condition with reported incidence of 0.1 to 2.4% [14]. While the etiology is unclear, it generally follows the local stimulation of the penis during skin preparation or instrumentation [3, 5]. Intraoperative penile erection may lead to delay or cancellation of the surgery by impeding urological instrumentation or safely reaching the prostate or bladder together with the greater risk of complications such as bleeding, urethral trauma and stricture formation [2, 4, 6].
To date, many pharmacological treatments to produce detumescence have been proposed, such as intracavernous injection of ephedrine, phenylephrine, metaraminol, noradrenaline and adrenaline [4, 710] or intravenous injection of ketamine [6, 1113], dexmedetomidine [5], terbutaline [14] and glycopyrrolate [15].
However, each of these has shown varying levels of efficacy and safety with no consensus a fully effective treatment protocol without side-effects [46].
The aim of this paper was to present the prevalence of intraoperative penile erection in our endourological surgery practice and the utility of intravenous ketamine in the management of the condition.

Methods

Study population

Of 402 endoscopic urological procedures performed in our clinic over a 4-year (2015–2019) period, a total of 9 cases with intraoperative penile erection development impeding instrumentation during endourological surgery were included in this retrospective study.
Written informed consent was obtained from each patient following a detailed explanation of the objectives and protocol of the study which was conducted in accordance with the ethical principles stated in the “Declaration of Helsinki” and was approved by the Institutional Ethics Committee.

Assessments

Data on patient age, weight, height, American Society of Anesthesiologists (ASA) physical status classification system scores, type and duration of surgery, type and level of anesthesia, onset of erection, treatment characteristics and treatment outcome were recorded for each patient.

Management of intraoperative penile erection

Intravenous ketamine treatment, titrated to a total dose of up to 75 mg in accordance with Ramsay sedation score of 3, was administered to resolve penile tumescence and rigid erection, which prevented performance of surgery. All patients also received midazolam (0.02 mg/kg) and fentanyl (1 μg/kg) to prevent ketamine-related complications. The surgical procedure was restarted in those with a successfully resolved rigid erection.

Statistical analysis

Statistical analysis was made using computer software (SPSS version 22.0, IBM, NY,USA). Descriptive statistics were stated as mean ± standard deviation (SD), median, IQR (Inter Quartil Range) and percentage (%), where appropriate.

Results

Overall endourological surgery population

The characteristics of the overall endourological surgery population (n = 402) are presented in Table 1. The mean age was 69.1 ± 10.2 years. TURP (38.1%) and TURBT (28.4%) were the most common operations. Spinal anesthesia was applied to the majority of patients (72.9%) and the average duration of surgery was 53.4 min. Intraoperative penile erection developed in 9 (2.2%) patients (Table 1).
Table 1
Characteristics of the overall endourological surgery population (n = 402)
Overall patient characteristics (n = 402)
Age (years), mean (SD)
 
69.1 (10.2)
Median (IQR)
 
69 (13)
Weight (kg)
 
78.4 (11.3)
 
78 (15)
Height (cm)
 
171.9 (5.9)
 
172 (8)
ASA physical status category, n (%)
I
151 (37.6)
II
239 (59.5)
III
12 (2.9)
Comorbidities, n (%)
Hypertension
 
174 (43.3)
Type 2 diabetes mellitus
 
81 (20.1)
Coronary artery disease
 
47 (11.7)
Arrhythmia
 
48 (11.9)
Chronic obstructive pulmonary disease
 
36 (9.0)
Chronic renal failure
 
5 (1.2)
Thyroid disease
 
8 (2.0)
Obstructive sleep apnea syndrome
 
2 (0.5)
Ankylosing spondylitis
 
TURP
153 (38.1)
Type of surgery, n(%)
TURBT
114 (28.4)
Cystoscopy
84 (20.9)
Internal urethrotomy
8 (2.0)
Ureteroscopy
2 (0.5)
Cystolithotomy
7 (1.7)
Endoscopic ureter stone
14 (3.5)
TUR biopsy
20 (5)
Duration of surgery (min), mean (SD) 53.4 (26.0)
 
53.4 (26.0)
Type of anesthesia, n (%)
Spinal
293 (72.9)
General anesthesia
109 (27.1)
Intraoperative penile erection,n(%)
Yes
9 (2.2)
No
393 (97.8)
ASA American Society of Anesthesiologists, TURP Transurethral resection of the prostate, TURBT Transurethral resection of bladder tumor

Cases with intraoperative penile erection

The individual and total characteristics of cases with intraoperative penile erection (n = 9) are presented in Table 2.
Table 2
Cases with intraoperative penile erection (n = 9)
Case
ASA
Typeof surgery
Duration of surgery
Anesthesia/Level
Onset of erection
Treatment
Outcome
1
1
TURP
55
Spinal/T10
Post-urethroscope
Ketamine 75 mg
Conversion to GA
2
1
TURP
90
Spinal/T8
Post-urethroscope
Ketamine 25 mg
Delayed procedure
3
2
TURBT
130
Spinal/T8
Post-urethroscope
Ketamine 50 mg
Conversion to GA
4
1
TURP
140
Spinal/T10
Pre-urethroscope
Ketamine 25 mg
Delayed procedure
5
2
TURBT
40
Spinal/T10
Post-urethroscope
Ketamine 20 mg
Delayed procedure
6
2
TURP
90
Spinal/T8
Post-urethroscope
Ketamine 21 mg
Delayed procedure
7
1
TURP
95
Spinal/T8
Post-urethroscope
Ketamine 18 mg
Delayed procedure
8
1
TURP
90
Spinal/T10
Pre-urethroscope
Ketamine 25 mg
Delayed procedure
9
2
TURP
95
Spinal/T8
Post-urethroscope
Ketamine 50 mg
Delayed procedure
Total (n = 9)
Age (years)
Mean (SD)
 
68.3 (6.6)
    
Weight (kg), mean (SD)
Median (IQR)
 
69.0 (8)
    
Median (IQR)
  
80.7 (7.8)
    
Height (cm), mean (SD)
  
82 (6)
    
Median (IQR)
 
172 (5)
174.6 (7.7)
    
ASA physical status
       
category, n (%)
I
 
5 (55.6)
    
Type of operation, n (%)
II
 
4 (44.4)
    
TURP
 
7 (77.8)
    
Type of anesthesia, n (%)
TURBT
 
2 (22.2)
    
Spinal
 
9 (100.0)
    
Level of anesthesia, n (%)
General
 
0 (0.0)
    
T10
 
4 (44.4)
    
T8 Post
 
5 (55.6)
    
Onset of erection
urethroscope Pre
 
7 (77.8)
    
urethroscope
 
2 (22.2)
    
Ketamine total dose (mg)
Mean (SD)
 
34.3 (19.5)
    
 
Median (min-max)
 
25.0 (18.0–75.0)
    
Duration of operation (min)
Mean (SD)
 
91.7 (31.3)
    
Median (min-max)
 
90.0 (40.0–140.0)
    
Outcome, n (%)
Resolved-delayed procedure
 
7 (77.8)
    
Conversion to general anesthesia
 
2 (22.2)
    
ASA American Society of Anesthesiologists, TURP Transurethral resection of the prostate, TURBT transurethral resection of bladder tumor
The mean (SD) age was 68.3 years (range, 66.0–77.0 years). ASA physical status category I 6 7 and II were noted in 55.6 and 44.4% of patients, respectively. All cases received spinal anesthesia (n = 9) at T8–10 dermatome levels, for TURP in 7 (77.8%) cases and for TURBT in 2 (22.2%) cases. The onset of penile erection was post-urethroscope in 7 (77.8%) cases. The average total ketamine dose was 34.3 mg (range, 18.0–75.0 mg) and the duration of the operation was mean 91.7 min (range, 40.0–140.0 min). Ketamine treatment resulted in resolved erection with delayed procedure in 7 (77.8%) cases, while conversion to general anesthesia was required in 2 (22.5%) cases (Table 2).
The cases with ketamine failure included a 74-year old patient undergoing TURP and a 77-year old patient undergoing TURBT and both were post-urethroscopic rigidities (Table 2).

Discussion

The findings of this study revealed that of 402 endourology operations performed in our clinic over a 4-year period (2015–2019), 9 (2.2%) patients had a penile erection during endourological surgery with spinal anesthesia. Overall, 7 of 9 (77.8%) cases were successfully treated with intravenous ketamine (total dose ranged from 18.0 to 75.0 mg) administration, which resolved penile rigidity and the operation was completed within 91.7 min on average.
The overall prevalence of intraoperative penile erection under anesthesia has been reported to range from 0.1 to 2.4% [5], specifically at 0.34–3.5% for general anaesthesia, 0.11–0.3% for spinal anaesthesia and 1.72–3.8% for epidural anaesthesia [35]. Hence, the prevalence of intraoperative penile erection in the current cohort of endourology patients seems to be consistent with previously reported rates for endourology procedures performed under spinal anesthesia.
Although the exact mechanism has not been clarified, penile erection under anesthesia is considered to be mediated by both psychogenic and refloxogenic stimulation [4, 14], while the latter is considered to be more common via the stimulatory effect of washing, touching and 6 7 instrumentation of the genital area on sacral root afferents [4]. Therefore, with the onset of penile erection post-urethroscope in 77.8% of the current study cases, these findings support the view that intraoperative penile erection generally follows local stimulation of the penis during skin preparation or instrumentation due to activation of sacral parasympathetic pathways eliciting an unopposed reflex response via an autonomic imbalance [35]. In addition, all of the intraoperative penile erection cases in this cohort had received spinal anesthesia with T8-T10 blockage, in accordance with the higher prevalence of erections with blocks reaching higher than T8 and rarely with those lower than T12 [16].
Notably, while the condition has been considered to occur predominantly in younger males [35], in the current cohort, the median age of patients with intraoperative penile erection was 69.0 years (range, 60.0–77.0 years), with the potential likelihood of treatment failure in older patients.
These findings demonstrated that the intravenous injection of ketamine was an effective and safe method for immediate relief of intraoperative penile erection with a high success rate. This supports the reported efficacy of ketamine, as a dissociative anesthetic, in the management of intraoperative penile erection in past studies [2, 6, 1113].
Moreover, in 7 of 9 cases, ketamine administration resolved penile rigidity enabling completion of the operation within an average of 91.7 min with no side-effects. This seems notable given the consideration of prolonged time to achieve flaccidity (range, 90 min− 2 h) being the major disadvantage of intravenous ketamine treatment, together with the potential risk of hallucinations and unpleasant dreams in patients under concomitant spinal anesthesia [4, 11, 17].
Certain limitations to this study should be considered. First, due to the retrospective single 1 2 3 4 5 center design of the study, establishing the temporality between cause and effect seems difficult. Second, generalizing these findings to the whole endourology population is not 6 7 possible due to the relatively low sample size. Nevertheless, despite these certain limitations, given the paucity of solid information available in accordance with the rarity of the condition and the challenges regarding conduction of very large-scale studies to determine the benefits of any therapeutic intervention, these findings represent a valuable contribution to the literature.

Conclusion

In conclusion, the prevalence of intraoperative penile erection during spinal anesthesia for endourological surgery was 2.2% in our experience. These findings demonstrated that intravenous injection of ketamine is an effective and safe method for immediate resolution of intraoperative penile erection with a high success rate.

Acknowledgements

Not applicable.
This research is retrospective and involving the collection of existing data and records. The ethical committee of Baskent University approved all procedures of the study and written informed consent was obtained from all cases.
Consent was obtained.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Walther PJ, Meyer AF, Woodworth BE. Intraoperative management ofpenile 11 12 erection with intracorporeal phenylephrine during endoscopic surgery. J Urol. 1987;137:738–9.CrossRef Walther PJ, Meyer AF, Woodworth BE. Intraoperative management ofpenile 11 12 erection with intracorporeal phenylephrine during endoscopic surgery. J Urol. 1987;137:738–9.CrossRef
2.
Zurück zum Zitat Baltogiannis DM, Charalabopoulos AK, Giannakopoulos XK, Giannakis DJ, Sofikitis NV, Charalabopoulos KA. Penile erection during transurethral surgery. J Androl. 2006;27:376–80.CrossRef Baltogiannis DM, Charalabopoulos AK, Giannakopoulos XK, Giannakis DJ, Sofikitis NV, Charalabopoulos KA. Penile erection during transurethral surgery. J Androl. 2006;27:376–80.CrossRef
3.
Zurück zum Zitat Staerman F, Nouri M, Coeurdacier P, Cipolla B, Guille F, Lobel B. Treatment of the intraoperative penile erection with intracavernous phenylephrine. J Urol. 1995;153:1478–81.CrossRef Staerman F, Nouri M, Coeurdacier P, Cipolla B, Guille F, Lobel B. Treatment of the intraoperative penile erection with intracavernous phenylephrine. J Urol. 1995;153:1478–81.CrossRef
4.
Zurück zum Zitat Gray M, Vasdev N, Gowrie-Mohan S, McNicholas T (2017) The Managementof unplanned erection during endoscopic urological surgery. Curr Urol10:113–117.CrossRef Gray M, Vasdev N, Gowrie-Mohan S, McNicholas T (2017) The Managementof unplanned erection during endoscopic urological surgery. Curr Urol10:113–117.CrossRef
5.
Zurück zum Zitat Guler G, Sofikerim M, Ugur F, Aksu R, Boyaci A. Intravenous dexmedetomidine for treatment of intraoperative penile erection. Int UrolNephrol. 2012;44:353–7. Guler G, Sofikerim M, Ugur F, Aksu R, Boyaci A. Intravenous dexmedetomidine for treatment of intraoperative penile erection. Int UrolNephrol. 2012;44:353–7.
6.
Zurück zum Zitat Tuncali B, Tuzel E. Management of Penile Erection Using IntravenousKetamin which is impeding urologic instrumentation under spinal anesthesia: CaseReport. Turkiye Klinikleri J Urology. 2014;5:62–5. Tuncali B, Tuzel E. Management of Penile Erection Using IntravenousKetamin which is impeding urologic instrumentation under spinal anesthesia: CaseReport. Turkiye Klinikleri J Urology. 2014;5:62–5.
7.
Zurück zum Zitat Siegel JF, Reda E. Intracorporeal phenylephrine reduces thioridazine (Mellaril) induced priapism in a child. J Urol. 1997;157:648. Siegel JF, Reda E. Intracorporeal phenylephrine reduces thioridazine (Mellaril) induced priapism in a child. J Urol. 1997;157:648.
8.
Zurück zum Zitat de Meyer JM, De Sy WA. Intracavernous injection of noradrenaline tointerrupt erections during surgical interventions. Eur Urol. 1986;12:169–70.CrossRef de Meyer JM, De Sy WA. Intracavernous injection of noradrenaline tointerrupt erections during surgical interventions. Eur Urol. 1986;12:169–70.CrossRef
9.
Zurück zum Zitat Zappala SM, Howard PJ, Hopkins TB, Blute RD. Management of intraoperative penile erections with diluted epinephrine solution. Urology. 1992;40:76–7.CrossRef Zappala SM, Howard PJ, Hopkins TB, Blute RD. Management of intraoperative penile erections with diluted epinephrine solution. Urology. 1992;40:76–7.CrossRef
10.
Zurück zum Zitat Tsai SK, Hong CY. Intracavernosal metaraminol for treatment ofintraoperative 6 7 penile erection. Postgrad Med. 1990;J66:831–3.CrossRef Tsai SK, Hong CY. Intracavernosal metaraminol for treatment ofintraoperative 6 7 penile erection. Postgrad Med. 1990;J66:831–3.CrossRef
11.
Zurück zum Zitat Benzon HT, Leventhal JB, Ovassapian A. Ketamine treatment of penileerection in the operating room. Anesth Analg. 1983;62:457–8.CrossRef Benzon HT, Leventhal JB, Ovassapian A. Ketamine treatment of penileerection in the operating room. Anesth Analg. 1983;62:457–8.CrossRef
12.
Zurück zum Zitat van Arsdalen KN, Chen JW, Smith MJ. Penile erectioncomplicating transurethral surgery. J Urol. 1983;129:374–86.CrossRef van Arsdalen KN, Chen JW, Smith MJ. Penile erectioncomplicating transurethral surgery. J Urol. 1983;129:374–86.CrossRef
13.
Zurück zum Zitat Gale AS. Ketamine prevention of penile turgescence. JAMA. 1972;219:1629.CrossRef Gale AS. Ketamine prevention of penile turgescence. JAMA. 1972;219:1629.CrossRef
14.
Zurück zum Zitat Shantha TR. Intraoperative management of penile erection by usingterbutaline. Anesthesiol. 1989;70:707–9.CrossRef Shantha TR. Intraoperative management of penile erection by usingterbutaline. Anesthesiol. 1989;70:707–9.CrossRef
15.
Zurück zum Zitat Valley MA, Sang CN. Use of glycopyrrolate to treat intraoperativepenile erection: case report and review of the literature. Reg Anesth. 1994;19:423–8.PubMed Valley MA, Sang CN. Use of glycopyrrolate to treat intraoperativepenile erection: case report and review of the literature. Reg Anesth. 1994;19:423–8.PubMed
16.
Zurück zum Zitat Pertek JP, Coissard A, Artis M. Dorsal nerve block forintraoperative management of penile erection. Reg Anesth. 1996;21:491–2.PubMed Pertek JP, Coissard A, Artis M. Dorsal nerve block forintraoperative management of penile erection. Reg Anesth. 1996;21:491–2.PubMed
17.
Zurück zum Zitat Ravindran RS, Dryden GE, Somerville GM. Treatment of priapismwith ketamine and physostigmine. Anesth Analg. 1982;61:705–7.PubMed Ravindran RS, Dryden GE, Somerville GM. Treatment of priapismwith ketamine and physostigmine. Anesth Analg. 1982;61:705–7.PubMed
Metadaten
Titel
The utility of intravenous ketamine for the management of intraoperative penile erection: a retrospective single-center analysis of endourological surgeries over a 4-year
verfasst von
Aşkın Eroğlu
Bahattin Tuncalı
Rahmi Gökhan Ekin
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Urology / Ausgabe 1/2020
Elektronische ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-0574-1

Weitere Artikel der Ausgabe 1/2020

BMC Urology 1/2020 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.